The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
This is very welcome news. The company have a steady announcement of new products and new contracts. Very promising, great potential, and they are heading in the right direction.
https://www.londonstockexchange.com/news-article/DCTA/italian-patent-grant-for-shoe-outsoles/14634288
I'm surprised there are no other messages about the RNS this morning. It looks like extremely positive news. A 9-year contract signed with Italdesign (part of Volkswagen AG). This is extremely promising.
Does anyone have a formula to extrpolate from drill results to tonnes or ore, and/or to grams of Au likely to be recovered?
For example, from RNS on 27 July, what is the normal method of extrapolating from "1.5km gold zone, 8m @ 7.4g/t Au" to a range of expected grams of Au recovered?
Does anyone have a formula to extrpolate from drill results to tonnes or ore, and/or to grams of Au likely to be recovered?
For example, from today's RNS, what is the normal method of extrapolating from "1.5km gold zone, 8m @ 7.4g/t Au" to a range of expected grams of Au recovered?
This is an extremely positive news release with solid and significant progress being report. Especially welcome is their resolve to have a two-gene test developed. The unfortunate fact that France did not grant Novacyt approval for its one-gene test was a significant blow to investors' confidence. With the two-gene test firmly on the delivery schedule, this will immediately firm up investor confidence markedly, and when delivery if announced in September, I expect the confidence levels to be fully restored.
Of additional reassurance to investors it that the two-gene test will indeed be launched by end of September. The confidence in their statement and their past proven performance leaves me with no doubt.
The other things they have been working on dilligently are all very important and relevant. This is a good company, competent company that have consistently and is currently bringing important health improvements to society.
Thanks for posting the link to the claim document, stokey12. A couple of key points occurred to me.
Eqtec was advised about the alleged patent infringement on three occasions: 30 Jan, 22 Apr, and 16 Jun. So I want to know why Eqtec did not inform the market via an RNS about this earlier.
Eqtec said in their 13 July RNS that they consider the claim to be opportunistic because it was filed on the same day as the Placing. I think this is very tenuous, and the opposite seems more likely. The legal filing will have been worked on for many days if not weeks. Would it benefit the claimants to submit the claim on the same day as the Placing? I can't see how. But on the other hand, I can see it would benefit Eqtec to, upon notification of the claim on 9 July, proceed with a quick Placing (it was announced and completed within 5 hours) to extract money from investors before the investors became aware of the potential problems.
The claim mentions that one of the patents was issued on 7 Apr 2020, but manufacture of at least one of Eqtec's gasefier installations was under way in Aug 2019. I'm not sure how a retrospective patent claim would work.
The claim asks for Eqtec to stop making and selling certain gasefiers. Should the claim be upheld, how much of Eqtec's US revenue will be affected, and what is the likely compensation claim?
Has FARN, ODX, and all the COVID stocks risen today because of the news from SNG? Is everyone expecting that if SNG have achieved a result, then other other companies might be close, too? Or is this just general sentiment improving towards COVID stocks?
The share price rose to around 70p back in March/April when they announced that they were developing SNG001. Now that they have announced that SNG001 is effective, the share price will, at the very least, return to 70p. Given that the results show that SNG001 is effective and can be used for treatment, the potential for this company has shifted from a "maybe" to a "definte". I would expect at least double the March/April price, so around £1.40 sounds reasonable.
I made amistake there, didn't I?! With 10 testing stations, it would take 8 hours! You need 100 testing stations. Then 500 people could be tested in 1 hour.
PDMSPiper, you mention that testing 500 plane passengers will take too long because each test takes 10 minutes each. But these tests could be done concurrently, not sequentially. If there are 10 testing stations, then 500 people can be tested in about an hour - much more feasible with regards to time. But I agree it would be a logistical nightmare.
I think it highly unlikely that the first EQT heard of the complaint was on 9 July. As with many leal cases, there may already have been a lot of negotiations going on "out of court"in preceeding weeks and months.
I notice in the RNS they don't say the date EQT became aware of the complaint (was it on 9th, 10th, or over the weekend?).
I also note the warning in the RNS:
"...the Group could be the subject of spurious and unfounded potential claims in relation to patent protection from time to time."
So we had all better get used to this.